background
previou
find
show
corticosteroid
treatment
first
acut
wheez
episod
may
reduc
recurr
wheez
children
high
rhinoviru
genom
load
followup
longerterm
effect
investig
prospect
method
pcr
confirm
rhinoviru
nasopharyng
aspir
children
first
acut
wheez
episod
random
receiv
oral
prednisolon
placebo
day
initi
asthma
control
medic
age
year
confirm
medic
record
andor
parent
interview
outcom
time
initi
regular
asthma
control
medic
interact
analysi
examin
rhinoviru
genom
load
result
fiftynin
children
complet
followup
asthma
control
medic
initi
children
median
age
month
overal
prednisolon
affect
time
initi
asthma
control
medic
compar
placebo
rhinoviru
load
modifi
effect
prednisolon
regard
time
initi
asthma
control
medic
pvalu
children
high
rhinoviru
load
copiesml
risk
initi
medic
lower
prednisolon
group
compar
placebo
group
placebo
group
asthma
medic
initi
children
high
rhinoviru
load
month
first
wheez
episod
overal
prednisolon
affect
time
initi
asthma
control
medic
compar
placebo
howev
prednisolon
may
benefici
firsttim
wheez
children
whose
episod
sever
associ
high
rhinoviru
load
clinicaltrialsgov
asthma
corticosteroid
prednisolon
rhinoviru
viru
load
wheez
abbrevi
oh
beo
blood
eosinophil
count
ci
confid
interv
hr
hazard
ratio
ic
inhal
corticosteroid
ige
immunoglobulin
e
iqr
interquartil
rang
oc
oral
corticosteroid
rct
random
control
trial
rsv
respiratori
syncyti
viru
sd
standard
deviat
system
corticosteroid
treatment
found
effect
acut
treatment
secondari
prevent
asthma
young
wheez
children
overal
limit
prior
studi
lack
subgroup
analys
might
identifi
respons
children
rhinovirusinduc
wheez
strongli
associ
recurr
wheez
asthma
age
year
previous
shown
two
random
control
trial
rct
firsttim
wheez
children
use
post
hoc
prospect
design
cours
oral
corticosteroid
oc
may
reduc
risk
recurr
wheez
especi
children
high
rhinoviru
genom
load
previous
use
design
rct
effect
oc
treatment
wheez
recurr
rhinovirusaffect
firsttim
wheez
children
investig
month
current
analysi
aim
investig
need
initi
regular
asthma
control
medic
followup
base
previou
find
hypothes
children
high
rhinoviru
genom
load
effect
oc
like
last
beyond
month
reduc
need
initi
longterm
asthma
control
medic
random
placebocontrol
trial
vinku
mean
wheez
finnish
prospect
investig
longterm
effect
short
cours
oral
prednisolon
prednisolon
leira
takeda
helsinki
finland
first
rhinovirusinduc
wheez
episod
first
dose
mgkg
mgkgd
dose
day
maximum
mgd
given
minc
mg
tablet
age
five
inclus
criteria
age
month
deliveri
gestat
week
first
acut
wheez
episod
parent
report
confirm
medic
record
nasopharyng
aspir
posit
rhinoviru
pcr
exclus
criteria
chronic
nonatop
ill
previou
system
inhal
corticosteroid
treatment
ic
need
intens
care
unit
treatment
studi
approv
ethic
committe
turku
univers
hospit
commenc
obtain
written
inform
consent
guardian
studi
entri
patient
examin
studi
physician
blood
sampl
nasopharyng
aspir
taken
children
reexamin
studi
physician
week
month
month
year
first
wheez
episod
parent
interview
studi
physician
use
standard
questionnair
studi
entri
followup
electron
patient
chart
review
regard
asthma
medic
therapi
adher
asthma
symptom
full
followup
period
random
protocol
describ
earlier
trial
doubleblind
followup
clinicaltrialsgov
primari
outcom
time
initi
asthma
control
medic
age
year
initi
medic
base
nation
asthma
educ
prevent
program
naepp
guidelin
diagnosi
asthma
children
age
year
need
asthma
control
medic
defin
wheez
episod
diagnos
physician
within
year
last
day
affect
sleep
addit
one
major
risk
factor
physician
diagnos
atop
eczema
aeroallergen
sensit
parent
histori
asthma
two
minor
risk
factor
wheez
apart
cold
blood
eosinophil
count
beo
l
food
sensit
andor
prolong
symptom
last
week
requir
symptomat
treatment
day
per
week
andor
two
exacerb
requir
system
corticosteroid
within
month
children
asthma
control
medic
start
third
acut
wheez
episod
accord
finnish
guidelin
interact
analysi
includ
effect
rhinoviru
genom
load
ie
copi
number
effect
prednisolon
vs
placebo
main
outcom
inhous
pcr
test
use
detect
rhinoviru
speci
b
c
enterovirus
respiratori
syncyti
viru
rsv
b
nasopharyng
aspir
inhous
commerci
pcr
test
use
accord
experi
sensit
test
especi
concern
detect
rhinoviru
differ
rhinoviru
rsv
detect
either
inhous
multiplex
pcr
defin
posit
human
bocaviru
analyz
use
pcr
serolog
beo
total
allergenspecif
serum
immunoglobulin
e
ige
level
analyz
use
routin
diagnost
procedur
origin
power
analysi
perform
followup
baselin
differ
patient
characterist
treatment
group
analyz
use
test
age
mannwhitney
u
test
beo
total
ige
oh
rhinoviru
genom
load
durat
breast
feed
delay
start
studi
drug
chisquar
test
sex
sensit
eczema
parent
allerg
rhiniti
patern
smoke
pet
ownership
coinfect
fisher
exact
test
count
admiss
ward
atop
eczema
parent
asthma
matern
smoke
viru
etiolog
cox
model
use
risk
primari
outcom
includ
main
effect
dichotom
rhinoviru
genom
load
intervent
group
interact
effect
rhinoviru
genom
load
intervent
group
cox
model
includ
covari
signific
differ
patient
characterist
found
surviv
time
censor
age
year
event
occur
earlier
cutoff
level
rhinoviru
genom
load
identifi
test
differ
copi
number
level
threshold
select
consid
signific
pvalu
rhinoviru
load
vs
group
interact
effect
similar
previou
report
ibm
spss
version
spss
inc
chicago
ill
usa
use
statist
total
children
random
receiv
prednisolon
placebo
first
acut
wheez
episod
followup
period
children
exclud
analysi
due
insuffici
followup
time
dropout
nine
due
insuffici
data
rhinoviru
genom
load
one
due
initi
ic
anoth
reason
figur
final
children
analyz
inpati
outpati
exclud
patient
differ
includ
patient
accord
age
sex
atop
characterist
viral
etiolog
asthmarel
factor
list
tabl
tabl
studi
entri
mean
age
patient
month
standard
deviat
sd
month
sensit
eczema
tabl
twenti
children
least
two
virus
detect
airway
rhinoviru
genom
load
vari
across
patient
median
copiesml
interquartil
rang
iqr
patient
rhinoviru
genom
load
level
copiesml
tabl
median
delay
start
studi
drug
hour
iqr
treatment
group
differ
patient
characterist
shown
tabl
tabl
prednisolon
group
children
placebo
group
children
receiv
least
one
oc
cours
followup
differ
cutoff
level
rhinoviru
genom
load
test
three
differ
level
notic
statist
signific
tabl
differ
final
result
differ
significantli
depend
cutoff
data
shown
level
earlier
report
use
five
children
asthma
control
medic
start
third
acut
wheez
episod
overal
prednisolon
affect
time
initi
asthma
control
medic
compar
placebo
figur
howev
level
rhinoviru
genom
load
studi
entri
modifi
effect
prednisolon
term
time
initi
asthma
control
medic
rhinoviru
load
x
studi
drug
interact
figur
children
rhinoviru
genom
load
copi
ml
risk
initi
asthma
control
medic
lower
prednisolon
group
compar
placebo
group
hazard
ratio
hr
confid
interv
ci
figur
asthma
control
medic
exclus
start
placebotr
children
high
rhinoviru
load
within
subsequ
month
first
wheez
episod
figur
median
age
children
time
initi
asthma
medic
month
iqr
month
children
rhinoviru
genom
load
copiesml
differ
found
prednisolon
placebo
group
hr
ci
figur
clinic
signific
advers
event
report
acut
phase
first
random
placebocontrol
trial
investig
effect
oc
treatment
preschool
age
care
character
young
children
suffer
first
acut
rhinovirusinduc
wheez
episod
three
main
find
first
oc
found
effect
overal
regard
time
initi
asthma
control
medic
second
placebo
group
asthma
risk
high
regular
asthma
control
medic
initi
children
high
rhinoviru
genom
load
subsequ
month
first
acut
rhinovirusinduc
wheez
episod
third
short
cours
prednisolon
decreas
risk
asthma
control
medic
children
first
sever
wheez
episod
caus
high
rhinoviru
genom
load
find
line
previou
data
increas
asthma
risk
associ
earli
rhinovirusinduc
wheez
probabl
explan
associ
rhinoviru
infect
risk
asthma
may
preexist
airway
inflamm
asthmapron
children
predispos
rhinoviru
infect
moreov
high
rhinoviru
genom
load
associ
sever
airway
inflamm
asthmapron
patient
interferon
respons
defici
thu
increas
viru
replic
promot
type
tcell
respons
respiratori
epitheli
cell
moreov
rhinoviru
infect
may
intensifi
inflamm
increas
express
eotaxin
interleukin
well
stimul
immigr
eosinophil
macrophag
neutrophil
placebo
group
find
except
high
risk
initi
regular
asthma
control
medic
children
high
rhinoviru
genom
load
consist
earlier
find
nevertheless
surpris
speed
asthma
progress
children
clinic
oc
treatment
recommend
asthma
exacerb
children
effect
oc
secondari
prevent
asthma
confirm
overal
analysi
rct
studi
popul
especi
high
rhinoviru
load
like
repres
cluster
previou
studi
shown
higher
rhinoviru
genom
load
associ
sever
andor
longer
durat
acut
lower
respiratori
ill
previou
data
concern
longterm
outcom
beyond
month
use
f
g
u
r
e
time
initi
asthma
control
medic
children
random
receiv
prednisolon
placebo
first
rhinovirusinduc
wheez
episod
differ
found
overal
analysi
f
g
u
r
e
time
initi
asthma
control
medic
children
random
receiv
prednisolon
placebo
first
rhinovirusinduc
wheez
episod
data
repres
accord
rhinoviru
genom
load
children
rhinoviru
genom
load
copiesml
longer
time
initi
asthma
control
medic
prednisolon
group
compar
placebo
group
placebo
group
asthma
medic
initi
children
high
rhinoviru
genom
load
mo
first
wheez
episod
sensit
pcr
realtim
pcr
compar
previou
studi
convent
pcr
liquid
hybrid
also
allow
quantif
rhinoviru
genom
load
also
use
highli
concentr
sampl
previou
studi
find
relationship
viral
shed
outcom
use
nasal
wash
sampl
estim
genom
load
differ
methodolog
may
explain
appar
discrep
result
earlier
studi
strength
studi
includ
care
character
patient
rct
design
although
blind
open
plan
report
howev
studi
limit
sampl
size
small
larg
enough
gener
statist
signific
result
consist
previou
studi
patient
hospit
rais
question
generaliz
result
outpati
mild
wheez
ill
rhinoviru
diagnost
caus
delay
administr
studi
drug
could
contribut
lack
effect
prednisolon
overal
rhinoviru
analysi
addit
sensit
pcr
earlier
post
hoc
analysi
delay
initi
studi
drug
quantit
rhinoviru
detect
prednisolon
found
effect
children
rhinoviru
andor
eczema
inflammatori
profil
helper
helper
mediat
differ
subgroup
would
increas
interest
find
profil
moreov
mani
cutoff
level
rhinoviru
genom
load
signific
pvalu
studi
made
decis
line
earlier
followup
summari
earli
system
shortcours
prednisolon
treatment
may
benefici
reduc
risk
asthma
control
medic
first
year
firsttim
wheez
preschool
children
whose
episod
sever
associ
high
rhinoviru
genom
load
result
call
attent
differ
phenotyp
bronchiol
earli
wheez
like
respond
differ
differ
therapi
natur
cours
asthma
incept
may
modifi
highrisk
children
identifi
earli
even
time
first
wheez
episod
target
effect
intervent
strategi
